跳至主要内容
临床试验/CTRI/2026/04/109262
CTRI/2026/04/109262尚未招募不适用

Randomised controlled trial to evaluate the efficacy of Rajanyadi churna in management of Balatisar with reference to acute diarrhoea in children of age group 1 to 5 years

KIRAN RAMESH MUDGIRE1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2026年4月26日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
76
试验地点
1
主要终点
Reduction in Udarashoola

研究概览

简要总结

The present randomized parallel-group, open-label clinical trial aims to evaluate the efficacy of a classical Ayurvedic formulation, Rajanyadi churna in the management of Balatisar and compare its effects with kutajtwakchurna another classical formulation. A total of 76 participants diagnosed with Balatisar will be recruited and randomly  allocated into two groups.

Participants in the intervention group will receive Rajanyadi churna 600mg to 3000mg bd in powder form, while the comparator group will receive kutajtwakchurna bd for a duration of 5 days. Clinical assessments will be performed on 0th,3rd,5th day

The primary outcome measures include reduction in classical symptoms associated with Balatisar udarashoola, Daurbalya,and Degree of Dehydration.

Objective parameters including malavega ,udarashoola,Daubarlya,Malaswaroopa,Degree of Dehydration.

The study aims to generate scientific evidence regarding the effectiveness of classical Ayurvedic formulations in the management of  Balatisar and may provide a safe and cost-effective therapeutic option for patients.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
1.00 Year(s) 至 5.00 Year(s)(—)
性别
All

入选标准

  • Inclusion Criteria 1.Children with classical signs and symptoms of Balatisar (diarrhoea) .
  • 2.Children aged above 1 years upto 5 years, irrespective of gender, socioeconomic background and religion.
  • 3.parents of children willing to give written consent .

排除标准

  • Exclusion Criteria 1.Children exhibiting moderate to severe dehydration .
  • 2.Children with known case of systemic illnesses, congenital abnormalities, metabolic disorders, or immunodeficiency conditions.
  • 3.Children who require in-patient hospital care for their condition.

结局指标

主要结局

Reduction in Udarashoola

时间窗: 2 Days

Daurbalya and Degree of Dehydration

时间窗: 2 Days

次要结局

  • Changes in associated symptoms of(Malavega)

研究者

发起方
KIRAN RAMESH MUDGIRE
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

KIRAN RAMESH MUDGIRE

PMT’S AYURVED COLLEGE SHEVGAON

研究点 (1)

Loading locations...

相似试验